Source: Virtual Congress 2020 – Clinical and laboratory pharmacology in asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Kallieri (Athens, Greece), E. Zervas (Athens, Greece), K. Katsoulis (Thessaloniki, Greece), E. Fouka (Thessaloniki, Greece), K. Porpodis (Thessaloniki, Greece), K. Samitas (Athens, Greece), A. Papaioannou (Athens, Greece), M. Kipourou (Thessaloniki, Greece), P. Lyberopoulos (Athens, Greece), E. Gaki (Trikala , Greece), S. Vittorakis (Chania, Greece), M. Markatos (Chania, Greece), K. Dimakou (Athens, Greece), S. Ampelioti (Athens, Greece), S. Koukidou (Athens, Greece), M. Makris (Athens, Greece), M. Ntakoula (Athens, Greece), M. Mitrova (Thessaloniki, Greece), S. Papiris (Athens, Greece), N. Tzanakis (Crete, Greece), D. Papakosta (Thessaloniki, Greece), P. Bakakos (Athens, Greece), S. Loukides (Athens, Greece). Follow-up of patients with severe eosinophilic asthma receiving mepolizumab for one year in specialized asthma clinics in Greece.. 1414

Member's Comments

No comment yet.

Related content which might interest you: Clinical outcomes in non-eosinophilic versus eosinophilic asthma after 12 months specialist management Source: International Congress 2018 – Clinical markers of asthma Year: 2018 Prevalence of allergic asthma diagnosis in asthmatic patients visited by allergists and neumologists in Spain Source: Eur Respir J 2003; 22: Suppl. 45, 299s Year: 2003 A ten year follow-up of former paediatric asthma patients Source: Eur Respir J 2005; 26: Suppl. 49, 233s Year: 2005 A longitudinal follow-up of severe asthma patients receiving reslizumab Source: International Congress 2017 – Asthma management Year: 2017 One year of unscheduled visits for asthma exacerbations at a specialized clinic – characteristics of ²difficult to control² patients with multiple exacerbations Source: Annual Congress 2008 - Understanding airway inflammation Year: 2008 Non fulfillment adherence in a Czech outpatient department serving COPD and astma patients in one year Source: International Congress 2017 – Does economisation of medicine transfer into benefits for patients? Year: 2017 Real-life effectiveness of omalizumab in patients with severe persistent allergic (IgE-mediated) asthma at a single UK hospital Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009 Effect of allergic rhinitis on asthma-related hospitalization, GP visit and drug cost among adult asthmatic patients in the UK Source: Eur Respir J 2002; 20: Suppl. 38, 396s Year: 2002 ‘Real-life‘ persistence beyond the first year of omalizumab treatment in patients with severe allergic asthma: The R-Pixel study Source: Annual Congress 2011 - Asthma management and response Year: 2011 Experience with Mepolizumab in a cohort of patients with eosinophilic severe persistent asthma Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma Year: 2019 Children with frequent intermittent asthma have the most severe asthma exacerbations presenting to a tertiary children‘s hospital emergency department, compared to children with infrequent intermittent and persistent asthma Source: Annual Congress 2010 - Risk factors for allergic diseases in children Year: 2010 Prevalence of uncontrolled severe persistent asthma patients in pneumology and allergy hospital units in Spain Source: Eur Respir J 2007; 30: Suppl. 51, 634s Year: 2007 Follow-up of patients with moderate-severe allergic asthma treated with omalizumab Source: Annual Congress 2010 - Asthma: clinical aspects and treatment Year: 2010 Emergency visits for asthma: asthma exacerbations or poor asthma control? Source: Eur Respir J 2004; 24: Suppl. 48, 598s Year: 2004 Long-term effectiveness of omalizumab in patients with severe persistent allergic (IgE-mediated) asthma: Real-life data from 3 UK centres Source: Annual Congress 2012 - Asthma: risk factors and effect of anti-IgE Year: 2012 Discontinuation of benralizumab in Canadian patients with severe eosinophilic asthma Source: ERJ Open Res, 7 (4) 00465-2021; 10.1183/23120541.00465-2021 Year: 2021 Severe allergic asthma in routine outpatient care Source: Annual Congress 2009 - Epidemiology of asthma Year: 2009 10 Year evaluation of patients with severe uncontrolled allergic asthma treated with Omalizumab. Source: International Congress 2018 – Physiological and biological insights in asthma Year: 2018 A virtual asthma clinic for children: fewer routine outpatient visits, same asthma control Source: Eur Respir J, 50 (4) 1700471; 10.1183/13993003.00471-2017 Year: 2017 Effect of omalizumab treatment on allergic comorbidities in patients with severe allergic asthma – real life experience from Czech Anti-IgE Registry Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside Year: 2017